Accession Number:

AD1105950

Title:

Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Personal Author(s):

Corporate Author:

USAF HOSPITAL KEESLER AFB MS KEESLER AFB United States

Report Date:

2020-06-19

Abstract:

Coronavirus disease 2019 COVID-19 has swept the globe and poses unique treatment challenges for immunocompromised patients with hematologic malignancies. Here, we present the case of a 54-year-old man with follicular lymphoma, recently completing treatment with maintenance rituximab, who endured a protracted course of COVID-19. The patients case was complicated by evolving hypoxic respiratory failure, marked lymphopenia, and hypogammaglobulinemia, which ultimately led to treatment with COVID-19 convalescent plasma, resulting in clinical improvement. Presently, there is no definitive data on the efficacy ofCOVID-19 convalescent plasma in patients withCOVID-19 however, many trials are ongoing. We propose that this may be an effective treatment inpatients treated for lymphoma with subsequent lymphopenia and hypogammaglobulinemia.

Descriptive Note:

Journal Article - Open Access

Supplementary Note:

Clinical Lymphoma, Myeloma and Leukemia , 01 Jan 0001, 01 Jan 0001,

Pages:

0004

Descriptors:

Identifiers:

Subject Categories:

Communities Of Interest:

Distribution Statement:

Approved For Public Release;

File Size:

0.38MB

View The Document